Speaker illustration

Doctor Yanish Purmah

Sandwell and West Birmingham Hospitals NHS Trust, Birmingham (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Identifying the value of RVEF for the prediction of major cardiovascular outcomes: a study of 7,131 patients undergoing cardiovascular magnetic resonance imaging

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Systolic and Diastolic Function

Session: Cardiac Magnetic Resonance in Clinical Practice

Thumbnail

Effect of rivaroxaban on coagulation and inflammation biomarkers: results from an X-VeRT substudy

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Biomarkers - Heart Failure

Thumbnail

Elevated levels of BNP and fibroblast growth factor 23 in patients with atrial fibrillation : an analysis of 40 cardiovascular biomarkers in 667 unselected hospitalized patients.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Biomarkers - Heart Failure

Thumbnail

Relationship of rate and rhythm control strategies to adverse outcomes in patients with atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Clinical features and management of atrial fibrillation

Thumbnail

A pilot study analysing different plasma biomarkers in patients with and without atrial fibrillation identifies fibroblast growth factor 23.

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation

Thumbnail

Evolution of symptoms, rate, and rhythm control therapy in AF patients in Europe: a comparison of the PREFER in AF and PREFER in AF prolongation data sets.

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Clinic, electrocardiogram, laboratory findings cardioversion and drugs in atrial fibrillation

Thumbnail

This platform is supported by

logo Novo Nordisk